Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Daniel B Costa Susan E Costa Jorge Jason A Freed Paul A VanderLaan Sol Schulman |
| Publication date | October 31, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |